Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.
Source check: Source checked. Not independent scientific confirmation.
Finding: Machine learning integrated clinical imaging and genomic data to stratify high-grade serous ovarian cancer risk using patient outcomes.
Technology: Machine learning integrates clinical, imaging and genomic features to stratify high-grade serous ovarian cancer risk.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine learning integrates clinical, imaging and genomic features to stratify high-grade serous ovarian cancer risk.
- Test and result
- The study reports outcome-based risk stratification using integrated multimodal patient data.
- Limitation / still unknown
- The retrospective study does not establish prospective clinical utility or treatment benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s43018-022-00388-9 · https://pubmed.ncbi.nlm.nih.gov/35764743/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.